This is the first coronavirus vaccine to get a regulatory fix in the United States. Their vaccine candidate, known as BNT 162B2, will likely be available for use in high-risk people in the United States by the end of December, the companies said in a statement. The submission to the …
Read More »Pfizer and Bioentech to present their FDA today, for emergency approval for their coronavirus vaccine
